Medication adherence in schizophrenia

David L. Roberts; Dawn I. Velligan

doi:10.1016/j.ddstr.2011.10.001

Medication adherence in schizophrenia

David L. Roberts, Dawn I. Velligan

Department of Psychiatry & Behavioral Sciences

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

Antipsychotic medications enable many individuals with schizophrenia to live more rewarding and productive lives. However, this benefit hinges on patients taking medications as prescribed, and as many as half of all patients exhibit some degree of treatment nonadherence. The current review summarizes the results of a survey on medication nonadherence that was completed by 41 experts in the field. Results confirm the prevalence of the problem, and provide practical guidance for clinicians on measurement and management of nonadherence.

Original language	English (US)
Pages (from-to)	11-15
Number of pages	5
Journal	Drug Discovery Today: Therapeutic Strategies
Volume	8
Issue number	1-2
DOIs	https://doi.org/10.1016/j.ddstr.2011.10.001
State	Published - Jun 1 2011

ASJC Scopus subject areas

Molecular Medicine
Pharmacology
Drug Discovery

Access to Document

10.1016/j.ddstr.2011.10.001

Cite this

@article{f5e2ea76cb344a55bc2c094017e4ae6f,

title = "Medication adherence in schizophrenia",

abstract = "Antipsychotic medications enable many individuals with schizophrenia to live more rewarding and productive lives. However, this benefit hinges on patients taking medications as prescribed, and as many as half of all patients exhibit some degree of treatment nonadherence. The current review summarizes the results of a survey on medication nonadherence that was completed by 41 experts in the field. Results confirm the prevalence of the problem, and provide practical guidance for clinicians on measurement and management of nonadherence.",

author = "Roberts, {David L.} and Velligan, {Dawn I.}",

year = "2011",

month = jun,

day = "1",

doi = "10.1016/j.ddstr.2011.10.001",

language = "English (US)",

volume = "8",

pages = "11--15",

journal = "Drug Discovery Today: Therapeutic Strategies",

issn = "1740-6773",

publisher = "Elsevier Limited",

number = "1-2",

}

TY - JOUR

T1 - Medication adherence in schizophrenia

AU - Roberts, David L.

AU - Velligan, Dawn I.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Antipsychotic medications enable many individuals with schizophrenia to live more rewarding and productive lives. However, this benefit hinges on patients taking medications as prescribed, and as many as half of all patients exhibit some degree of treatment nonadherence. The current review summarizes the results of a survey on medication nonadherence that was completed by 41 experts in the field. Results confirm the prevalence of the problem, and provide practical guidance for clinicians on measurement and management of nonadherence.

AB - Antipsychotic medications enable many individuals with schizophrenia to live more rewarding and productive lives. However, this benefit hinges on patients taking medications as prescribed, and as many as half of all patients exhibit some degree of treatment nonadherence. The current review summarizes the results of a survey on medication nonadherence that was completed by 41 experts in the field. Results confirm the prevalence of the problem, and provide practical guidance for clinicians on measurement and management of nonadherence.

UR - http://www.scopus.com/inward/record.url?scp=84862196935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862196935&partnerID=8YFLogxK

U2 - 10.1016/j.ddstr.2011.10.001

DO - 10.1016/j.ddstr.2011.10.001

M3 - Review article

AN - SCOPUS:84862196935

SN - 1740-6773

VL - 8

SP - 11

EP - 15

JO - Drug Discovery Today: Therapeutic Strategies

JF - Drug Discovery Today: Therapeutic Strategies

IS - 1-2

ER -

Medication adherence in schizophrenia

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this